BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 147 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $128,000 | -20.0% | 41,029 | -7.8% | 0.00% | – |
| Q3 2021 | $160,000 | +19.4% | 44,510 | +19.3% | 0.00% | – |
| Q2 2021 | $134,000 | +44.1% | 37,301 | +57.2% | 0.00% | – |
| Q1 2021 | $93,000 | +14.8% | 23,729 | +23.8% | 0.00% | – |
| Q4 2020 | $81,000 | -96.7% | 19,168 | -95.0% | 0.00% | -100.0% |
| Q4 2019 | $2,437,000 | +147.9% | 385,670 | +108.0% | 0.00% | – |
| Q1 2019 | $983,000 | +19560.0% | 185,398 | +29328.3% | 0.00% | – |
| Q2 2015 | $5,000 | -100.0% | 630 | -100.0% | 0.00% | -100.0% |
| Q1 2015 | $44,055,000 | +19.7% | 4,195,711 | +37.1% | 0.02% | +21.4% |
| Q4 2014 | $36,798,000 | -16.1% | 3,061,431 | +19.3% | 0.01% | -22.2% |
| Q3 2014 | $43,841,000 | +2263.4% | 2,565,327 | +1569.6% | 0.02% | +1700.0% |
| Q2 2014 | $1,855,000 | +209.2% | 153,652 | +50.9% | 0.00% | – |
| Q4 2013 | $600,000 | +10.7% | 101,810 | +2.1% | 0.00% | – |
| Q3 2013 | $542,000 | -37.3% | 99,745 | -53.1% | 0.00% | – |
| Q2 2013 | $864,000 | – | 212,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |